Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neogenomics Inc (NQ: NEO )

14.80 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11
Open 14.80
Bid (Size) 13.01 (300)
Ask (Size) 15.60 (3)
Prev. Close 14.80
Today's Range 14.80 - 14.80
52wk Range 11.03 - 21.22
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
From NeoGenomics, Inc.
Via Business Wire
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
From NeoGenomics, Inc.
Via Business Wire

Performance

YTD
-7.21%
-7.21%
1 Month
+12.38%
+12.38%
3 Month
+10.28%
+10.28%
6 Month
-7.50%
-7.50%
1 Year
-11.43%
-11.43%

More News

Read More
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics Earnings Analysis: Q1 Recap
Via Benzinga
Where NeoGenomics Stands With Analysts
Via Benzinga
What 6 Analyst Ratings Have To Say About NeoGenomics
Via Benzinga
NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
NeoGenomics Reports First Quarter 2024 Results
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics Announces Senior Leadership Promotions
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
From NeoGenomics, Inc.
Via Business Wire
Evaluating NeoGenomics: Insights From 4 Financial Analysts
Via Benzinga
Recap: NeoGenomics Q4 Earnings
Via Benzinga
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
From NeoGenomics, Inc.
Via Business Wire
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
From NeoGenomics, Inc.
Via Business Wire
Earnings Scheduled For March 15, 2024
Via Benzinga
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
From NeoGenomics, Inc.
Via Business Wire
Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
Via Benzinga
NeoGenomics Stock Surged But Technicals Point To A Pullback
Via Talk Markets
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
Via Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.